⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

RAINBOW - Investment Analysis: Buy Signal or Bull Trap?

← Back to List

⭐ Rating: 2.3

Last Updated Time : 19 Sept 26, 01:47 am

Key Parameters

⭐ Investment Rating: 2.3

ROE13.8 %
ROCE16.3 %
PEG Ratio36.4
Dividend Yield0.24 %
Debt to equity0.47
PAT Qtr52.7 Cr.
PAT Prev Qtr60.4 Cr.
Qtr Profit Var1.91 %
Show all parameters (20 more)
Stock CodeRAINBOW
Market Cap14,787 Cr.
Current Price1,455 ₹
High / Low1,610 ₹
Stock P/E58.7
Book Value166 ₹
Face Value10.0 ₹
DMA 501,454 ₹
DMA 2001,384 ₹
Chg in FII Hold-1.21 %
Chg in DII Hold1.44 %
RSI48.8
MACD-3.42
Volume1,04,627
Avg Vol 1Wk87,962
Low price1,009 ₹
High price1,610 ₹
52w Index74.2 %
EPS24.7 ₹
Industry PE49.9

🏭 Industry

The healthcare sector, specifically children's hospitals and specialized clinics (as indicated by Rainbow Children’s Medicare), is generally considered stable but competitive. Regulatory changes and reimbursement policies can significantly impact profitability, necessitating careful monitoring of the industry landscape. Despite these challenges, the demand for pediatric healthcare services remains relatively resilient, potentially offering a degree of protection for established players like Rainbow Children's Medicare.

✅ Positive

The company demonstrates consistent profitability with a PAT of 52.7 Cr in the current quarter, despite a slight decrease from the previous quarter. Furthermore, the debt-to-equity ratio of 0.47 indicates a conservative capital structure, which is generally favorable for long-term stability and reduces financial risk.

⚠️ Limitation

The exceptionally high P/E ratio of 58.7, combined with a PEG ratio of 36.4 – both significantly above the industry average – suggests that the stock is trading at a substantial premium. This elevated valuation raises concerns about overvaluation and potentially limits future upside potential if growth slows.

📉 Company Negative News

The recent analyst rating downgrade from MarketsMojo to ‘Hold’ indicates reduced confidence in the company's prospects, although it doesn't necessarily signal immediate trouble. Value Research’s shareholding pattern update shows a decrease in FII holding, which while not inherently negative, warrants observation.

🧾 Long-Term Outlook

An ideal entry price zone would be between 1,250 ₹ and 1,350 ₹, targeting a potential undervaluation based on the current metrics. A holding period of at least five to seven years is recommended, prioritizing consistent dividend income (at 0.24%) and capitalizing on compounding returns. The durability of the business hinges on its ability to maintain market share in a competitive sector, so continued monitoring of industry dynamics and regulatory changes is essential; despite the high valuation, the company’s stability appears reasonably solid due to low debt.

Choose Technical Analysis or Fundamental Analysis above to load it.

How RAINBOW Rates Across All Strategies

★ 2.3
Entry Price: 1,430 ₹ – Initiate a long position with an entry point j…
★ 2.3
Buy Price: 1,450 ₹.
Investment
★ 2.3
You're viewing this analysis below.
★ 2.3
An entry zone around 1,300 ₹ – 1,350 ₹ reflects a cautious approach g…

NIFTY 50 · Investment

NEXT 50 · Investment

MIDCAP · Investment

SMALLCAP · Investment